This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES . T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 1991; 15: 17–21.
Au WY, Ng WM, Choy C, Kwong YL . Aggressive subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine, mitoxantrone and dexamethasone. Br J Dermatol 2000; 143: 408–410.
Ghobrial IM, Weenig RH, Pittlekow MR, Qu G, Kurtin PH, Ristow K et al. Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphoma. Leuk Lymphoma 2005; 46: 703–708.
Shani-Adir A, Lucky AW, Prendiville J, Murphy S, Passo M, Huang FS et al. Subcutaneous panniculitic T-cell lymphoma in children: response to combination therapy with cyclosporine and chemotherapy. J Am Acad Dermatol 2004; 50 (2 Suppl): S18–S22.
Thomson AB, McKenzie KJ, Jackson R, Wallace WH . Subcutaneous panniculitic T-cell lymphoma in childhood: successful response to chemotherapy. Med Pediatr Oncol 2001; 37: 549–552.
Hoque SR, Child FJ, Whittaker SJ, Fereira S, Orchard G, Jenner K et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol 2003; 148: 516–525.
Go RS, Wester SM . Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature. Cancer 2004; 101: 1404–1413.
Leonard GD, Hegde U, Butman J, Jaffe ES, Wilson WH . Extraoular muscle palsies in subcutaneous panniculitis-like T-cell lymphoma. J Clin Oncol 2003; 21: 2993–2995.
Alaibac M, Berti E, Pigozzi B, Chiarion V, Aversa S, Marino F et al. High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma. J Am Acad Dermatol 2005; 52: S121–S123.
Enblad G, Hagberg H, Erlanson M, Lundin J, MacDonald AP, Repp R et al. A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas. Blood 2004; 103: 2920–2924.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pérez-Persona, E., Mateos-Mazón, J., López-Villar, O. et al. Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation. Bone Marrow Transplant 38, 821–822 (2006). https://doi.org/10.1038/sj.bmt.1705527
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705527
This article is cited by
-
Stem cell transplantation for T-cell lymphomas in Taiwan
Bone Marrow Transplantation (2018)
-
Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides
Current Hematologic Malignancy Reports (2016)
-
Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma
Bone Marrow Transplantation (2008)